18 years and older diagnosed with macromastia. Patients were excluded if they were not observed at least 12 months before and after diagnosis of macromastia, and if they had genetic susceptibility to breast cancer, prior benign or nonspecific breast disease, or prior personal/ family history of breast cancer. We identified a subgroup of patients who underwent screening and/or diagnostic mammography within 12 months of initial macromastia evaluation. We recorded additional procedures (MRI, ultrasound, and biopsy) performed within 3 months after mammography and new diagnoses of benign or malignant breast disease after mammography. For comparison rates of new diagnoses of benign or malignant breast disease, a cohort of women without macromastia from the general population 18 years and older was selected from the 2013 database. Age-specific rates of mammography use were compared between the macromastia and general population cohorts using the Chi-square test.
RESULTS:
The study cohort included 52,486 female patients diagnosed with macromastia. Mammography was used in 59.6% (N=31,284) of macromastia patients. Among macromastia patients 30-39 years of age, 30.1% underwent screening and/or diagnostic mammography, compared to 5.7% of the general population (P<0.001). Macromastia patients 29 years and younger also had a higher rate of mammography use (4.3%) compared to general population (0.2%) (P<0.001). Of the 3,657 macromastia patients age 39 years and younger who received mammography, 16.2% (N=593) received at least one subsequent test or procedure (MRI, ultrasound, or biopsy) within the 3 months following mammography, whereas only 0.46% (N=17) were diagnosed with malignant breast disease after mammography. A subsequent biopsy was performed in 8.3% (N=273) of macromastia patients age 39 years and younger (N=3,657) within 3 months of mammography.
CONCLUSION:
This study showed that rates of additional testing and invasive procedures after mammography are not inconsequential for patients in low risk age groups in the setting of evaluation for elective breast surgery. However, the incidence of breast cancer diagnosis is very low in this study population. Providers must realize the impact of mammography use in young patients prior to elective breast surgery as it translates to a real risk of additional studies and invasive procedures. However, families tend to have many more questions about the degree of scarring. We hypothesized that the lip angle, which is often the surgeon's focus, would be less influential than scar severity in layperson ratings. We used a novel technique of simulating different lip angles and scar thicknesses and assessed the relative contributions of these two factors via online crowdsourcing.
METHODS:
We received IRB approval for modifying patients' postoperative photos with Adobe Photoshop to create 5 levels of scarring (none, minimal, mild, moderate, severe) and 5 levels of lip angle (0, 5, 10, 15, and 20 degrees) . Each child's resulting 25 composite images were presented in pairs to internet raters using Amazon Mechanical Turk (300 unique pairs per child). Users selected the simulated postoperative result they felt had the most normal appearance. Picture pairs were presented four times each, with order counterbalanced for a total of 1200 trials per child. The Bradley Terry (BT) model was used to fit the data with different predictors: scar level alone, angle level alone, and scar and angle (with and without interaction term). The Akaike Information Criterion (AIC) was used to identify the best-fitting model. A smaller AIC value indicates a better model fit to the data, especially if the absolute difference is greater than 10. A Wald statistic tested whether each factor exerts equal influence on ratings.
RESULTS:
Two children with primary cleft lip repair had their postoperative photos used: 22-month-old boy (17-month follow-up) and 6 year, 3-month-old girl (5 year, 9-month follow-up). Twelve-hundred crowdsourced pairwise ratings were collected for each patient (2,400 combined
